Trials / Unknown
UnknownNCT03947528
Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
Detailed description
To evaluate the bioequivalence of two formulations of Sarpogrelate HCl 300mg after a single oral dose administration in healthy volunteers under fed conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sarpogrelate HCL 300mg | a single oral dose administration in healthy volunteers under fed condition |
Timeline
- Start date
- 2019-03-04
- Primary completion
- 2019-05-13
- Completion
- 2019-05-13
- First posted
- 2019-05-13
- Last updated
- 2019-05-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03947528. Inclusion in this directory is not an endorsement.